Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Cullinan Therapeutics

Tracked across 2 events · 13 articles · First seen May 26, 2026 · Last active Sep 14, 2026

Sentiment
45
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: Cullinan Therapeutics is hosting an Immunology Day to present new clinical data for its autoimmune disease therapies, CLN-978 and velinotamig, which could significantly impact its stock price and future development.
May 26, 2026 · 7 articles
2 30
Tech
Cullinan Therapeutics announced that it will host a virtual event for analysts and institutional investors on September 14, 2026, at 8:00 a.m. ET to discuss results from the planned interim analysis of the Phase 3…
Impact: Cullinan Therapeutics is the central company hosting the investor event and sponsor of the REZILIENT3 trial; positive data could boost its valuation and pipeline credibility.
Sep 10, 2026 · 6 articles
50 Cullinan Therapeutics announced virtual investor eventCullinan REZILIENT3...
ERGEN INTELLIGENCE
Track Cullinan Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.